Microdosing means using a much smaller dose of a GLP-1 medication than whats typically prescribed for diabetes or weight loss often a fraction of the standard starting dose
January 2024: The FDA said it was evaluating reports of hair loss, suicidal thoughts and aspiration under sedation and anesthesia among people taking Ozempic and similar diabetes and weight loss medications
Over time, we may see the cost going down, but right now these products are making a lot of money for these companies. Novo Nordisk ends Hims & Hers deal Novo Nordisk entered a partnership with Hims & Hers in April to make Wegovy more accessible to consumers, but ended the deal on Monday over claims the telehealth firm sold knockoff versions that put patient health at risk
Glucagon-like peptide 1 receptor (GLP-1 R) agonists This class of drugs (which includes liraglutide, exenatide, lixisenatide, and dulaglutide) acts on the pancreas, brain, and adipose tissue in a way similar to physiological GLP 1 and exerts its antidiabetic effect through controlling food intake, energy absorption, and glucose-dependent insulin secretion [69]